Doxycycline versus ceftriaxone for the treatment of patients with chronic Lyme borreliosis

Wiener Klinische Wochenschrift

Volumn 118, Issue 21-22, 2006, Pages 696-701

  Ogrinc, Katarina ^a   Logar, Mateja ^a   Lotrič Furlan, Stanka ^a   Cerar, Daša ^a   Ružić Sabljić, Eva ^b   Strle, Franc ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Borrelia burgdorferi sensu lato; Ceftriaxone; Cerebrospinal fluid; Lyme borreliosis; Treatment; doxycycline

Indexed keywords

ANTIBIOTIC AGENT; CEFTRIAXONE; DOXYCYCLINE;

ABDOMINAL PAIN; ANOREXIA; ARTICLE; BACTERIUM CULTURE; CEREBROSPINAL FLUID ANALYSIS; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIARRHEA; DIZZINESS; DRUG COST; DRUG EFFICACY; DRUG WITHDRAWAL; DYSPNEA; ESOPHAGITIS; GASTROINTESTINAL SYMPTOM; GLOSSITIS; HEADACHE; HUMAN; LABORATORY TEST; LYME DISEASE; NAUSEA; PHOTOSENSITIVITY; SEROLOGY; SKIN PRURITUS; VOMITING;

ADMINISTRATION, ORAL; ADULT; AGED; ANTI-BACTERIAL AGENTS; ANTIBODIES, BACTERIAL; BORRELIA BURGDORFERI; CEFTRIAXONE; CEREBROSPINAL FLUID; DOXYCYCLINE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INJECTIONS, INTRAVENOUS; LYME DISEASE; MALE; MIDDLE AGED; TIME FACTORS; TREATMENT OUTCOME;

EID: 33845675607     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00508-006-0698-7     Document Type: Article

References (29)

1. Zdravstveni statistični letopis, Slovenija (2003) Inštitut za varovanje zdravja republike Slovenije
2. Steere AC (2001) Lyme disease. N Engl J Med 345: 115-125
3. Nadelman RB, Wormser GP (1998) Lyme borreliosis. Lancet 352: 557-565
4. Strle F (1999) Principles of the diagnosis and antibiotic treatment of Lyme borreliosis. Wien Klin Wochenschr 111: 911-915
5. Stanek G, Strle F (2003) Lyme borreliosis. Lancet 362: 1639-1647
6. Jurca T, Ogrinc K (2000) Ambulantno zdravljenje s ceftriaksonom. In: Strle F (ed) Lymska borelioza 2000. 2. slovensko posvetovanje o lymski boreliozi. Ljubljana: 213-217
7. Ogrinc K, Lotrič-Furlan S, Maraspin V, Cimperman J, Ružić-Sabljić E, Strle F (2002) Cerebrospinal fluid findings in patients with symptoms suggesting chronic Lyme borreliosis. Wien Klin Wochenschr 114: 535-538
8. Wilske B, Preac-Mursic V (1993) Microbiological diagnosis of Lyme borreliosis. In: Weber K, Burgdorfer W, Shiery G (eds) Aspects of Lyme borreliosis. Springer, Berlin Heidelberg, pp 268-299
9. Ružić-Sabljić E, Strle F, Cimperman J, Maraspin V, Lotrič-Furlan S, Pleterski-Rigler D (2000) Characterisation of Borrelia burgdorferi sensu lato strains isolated from patients with skin manifestations of Lyme borreliosis residing in Slovenia. J Med Microbiol 49: 47-53
10. Ružić-Sabljić E, Maraspin V, Cimperman J, Lotrić-Furlan S, Strle F (2002) Evaluation of immunofluorescence test (IFT) and immuno (western) blot (WB) test in patients with erythema migrans. Wien Klin Wochenschr 114: 586-590
11. Preac-Mursic V, Wilske B, Schierz G (1986) European Borrelia burgdorferi isolated from humans and ticks. Culture conditions and antibiotic susceptibility. Zentralb Bakteriol Mikrobiol Hyg A 263: 112-118
12. Ružić-Sabljić E, Maraspin V, Lotrič-Furlan S, Jurca T, Logar M, Pikelj A, et al (2002) Characterization of Borrelia burgdorferi sensu lato strains isolated from human material in Slovenia. Wien Klin Wochenschr 114: 544-550
13. Wiltfang J, Esselmann H, Cupers P, Neumann M, Kretzschmar H, Beyermann M, et al (2001) Elevation of beta-amyloid peptide 2-42 in sporadic and familial Alzheimer's disease and its generation in PS1 knockout cells. J Biol Chem 276: 42645-42657
14. Zaremba J, Losy J (2001) The levels of TNF-alpha in cerebrospinal fluid and serum do not correlate with the white blood cells in acute phase of ischemic stroke. Folia Morphol 60: 91-97
15. Reindl M, Knipping G, Wicher I, Dilitz E, Egg R, Deisenhammer F, et al (2001) Increased intrathecal production of apolipoprotein D in multiple sclerosis. J Neuroimmunol 119: 327-332
16. Castro MP, McDonald TJ, Qualman SJ, Odorisio TM (2001) Cerebrospinal fluid gastrin releasing peptide in the diagnosis of leptomeningeal metastases from small cell carcinoma. Cancer 91: 2122-2126
17. Pruzanski W, Greenwald RA, Street IP, Laliberte F, Stefanski E, Vadas P (1992) Inhibition of enzymatic activity of phospholipases A2 by minocycline and doxycycline. Biochem Pharmacol 44: 1165-1170
18. Greenwald RA, Moak SA, Ramamurthy NS, Golub LM (1992) Tetracyclines suppress matrix metalloproteinase activity in adjuvant arthritis and in combination with flurbiprofen ameliorate bone damage. J Rheumatol 19: 927-938
19. D'Agostino P, La Rosa M, Barbera C, Arcoleo F, Di Bella G, Milano S, et al (1998) Doxycycline reduces mortality to lethal endotoxemia by reducing nitric oxide synthesis via an interleukin-10-independent mechanism. J Infect Dis 177: 489-492
20. Dotevall L, Hagberg L (1999) Successful oral doxycycline treatment of Lyme disease-associated facial palsy and meningitis. Clin Infect Dis 28: 569-574
21. Dotevall L, Alestig K, Hanner P, Norkrans G, Hagberg L (1988) The use of doxycycline in nervous system Borrelia burgdorferi infection. Scand J Infect Dis 53: 74-79
22. Borg R, Dotevall L, Hagberg L, Maraspin V, Lotrič-Furlan S, Cimperman J, et al (2005) Intravenous ceftriaxone compared with oral doxycycline for the treatment of Lyme neuroborreliosis. Scand J Infect Dis 37: 449-454
23. Dattwyler RJ, Luft BJ, Kunkel MJ, Finkel MF, Wormser GP, Rush TJ, et al (1997) Ceftriaxone compared with doxycycline for the treatment of acute disseminated Lyme disease. N Engl J Med 337: 289-294
24. Scheife RT, Levy M, Greenblatt DJ (1976) Antimicrobial agents. In: Miller RR, Greenblatt DJ (eds) Drug effects in hospitalized patients: experiences of the Boston Collaborative Drug Surveillance Program, 1966-1975. Wiley, New York, pp 263-264
25. rd (1991) Tetracyclines, chloramphenicol, erythromycin, clindamycin, and metronidazole. Mayo Clin Proc 66: 1270-1280
26. Dattwyler RJ, Halperin JJ, Volkman DJ, Luft BJ (1988) Treatment of late Lyme borreliosis - randomized comparison of ceftriaxone and penicillin. Lancet 1: 1191-1194
27. Krupp LB, Hyman LG, Grimson R, Coyle PK, Melville P, Ahnn S, et al (2003) Study and treatment of post Lyme disease (STOP-LD). Neurology 60: 1923-1930
28. Logigian EL, Kaplan RF, Steere AC (1999) Successful treatment of Lyme encephalopathy with intravenous ceftriaxone. J Infect Dis 180: 377-383
29. Eckman MH, Steere AC, Kalish RA, Pauker SG (1997) Cost effectiveness of oral as compared with intravenous antibiotic therapy for patients with early Lyme disease or Lyme arthritis. N Engl J Med 337: 357-363